Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital

About this trial

The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are:

1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?

Eligibility criteria

Qualifiers

Age: > or equal to 18 years

Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology

Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand & sign the informed consent document

Disqualifiers

Non-English speaking (PROM surveys are only validated in English)

Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies

Trial design

Treatments tested in this trial

  • Bone marrow aspirate concentrate (BMAC)
  • Control

Treatment groups

160 Participants
are divided into 2 treatment groups

Sponsors and collaborators